Modulation of the gut microbiome by novel synthetic glycans for the production of propionate and the reduction of cardiometabolic risk factors
Y. A. Millet, J. Meisner, J. Tan, A. Jose, E. Humphries, K. J. Miller, C. Bayne, M. McComb, M. Giuggio, C. M. Konopnicki, D. B. Belanger, L. Li, H. Yuan, M. Rosini, H. Luong, , J. E. van Hylckama Vlieg
This paper identifies a synthetic glycan, KB39, that increases propionate production by the gut microbiome and reduces cardiometabolic risk factors in mice.
bioRxiv · Apr 4, 2022 · PreprintMicrobiology